Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

The signal peptide of the tumor-shared antigen midkine hosts CD4+ T cell epitopes.

Kerzerho J, Schneider A, Favry E, Castelli FA, Maillère B.

J Biol Chem. 2013 May 10;288(19):13370-7. doi: 10.1074/jbc.M112.427302. Epub 2013 Apr 3.

PMID:
23553629
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.

Mandic M, Castelli F, Janjic B, Almunia C, Andrade P, Gillet D, Brusic V, Kirkwood JM, Maillere B, Zarour HM.

J Immunol. 2005 Feb 1;174(3):1751-9.

PMID:
15661941
[PubMed - indexed for MEDLINE]
Free Article
3.

Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1/Th2 lymphocytes.

Slager EH, van der Minne CE, Krüse M, Krueger DD, Griffioen M, Osanto S.

J Immunol. 2004 Apr 15;172(8):5095-102.

PMID:
15067093
[PubMed - indexed for MEDLINE]
Free Article
4.

Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy.

Schultz ES, Schuler-Thurner B, Stroobant V, Jenne L, Berger TG, Thielemanns K, van der Bruggen P, Schuler G.

J Immunol. 2004 Jan 15;172(2):1304-10.

PMID:
14707109
[PubMed - indexed for MEDLINE]
Free Article
5.

Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules.

Zeng G, Touloukian CE, Wang X, Restifo NP, Rosenberg SA, Wang RF.

J Immunol. 2000 Jul 15;165(2):1153-9.

PMID:
10878395
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Defining MHC class II T helper epitopes for WT1 tumor antigen.

Kobayashi H, Nagato T, Aoki N, Sato K, Kimura S, Tateno M, Celis E.

Cancer Immunol Immunother. 2006 Jul;55(7):850-60. Epub 2005 Oct 12.

PMID:
16220325
[PubMed - indexed for MEDLINE]
7.

NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.

Zarour HM, Maillere B, Brusic V, Coval K, Williams E, Pouvelle-Moratille S, Castelli F, Land S, Bennouna J, Logan T, Kirkwood JM.

Cancer Res. 2002 Jan 1;62(1):213-8.

PMID:
11782380
[PubMed - indexed for MEDLINE]
Free Article
8.

MAGE-A3 and MAGE-A4 specific CD4(+) T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes.

Cesson V, Rivals JP, Escher A, Piotet E, Thielemans K, Posevitz V, Dojcinovic D, Monnier P, Speiser D, Bron L, Romero P.

Cancer Immunol Immunother. 2011 Jan;60(1):23-35. doi: 10.1007/s00262-010-0916-z. Epub 2010 Sep 21.

PMID:
20857101
[PubMed - indexed for MEDLINE]
9.

Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen.

Kobayashi H, Wood M, Song Y, Appella E, Celis E.

Cancer Res. 2000 Sep 15;60(18):5228-36.

PMID:
11016652
[PubMed - indexed for MEDLINE]
Free Article
10.

Identification of naturally processed CD4 T cell epitopes from the prostate-specific antigen kallikrein 4 using peptide-based in vitro stimulation.

Hural JA, Friedman RS, McNabb A, Steen SS, Henderson RA, Kalos M.

J Immunol. 2002 Jul 1;169(1):557-65.

PMID:
12077288
[PubMed - indexed for MEDLINE]
Free Article
11.

Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen.

Novellino L, Renkvist N, Rini F, Mazzocchi A, Rivoltini L, Greco A, Deho P, Squarcina P, Robbins PF, Parmiani G, Castelli C.

J Immunol. 2003 Jun 15;170(12):6363-70.

PMID:
12794170
[PubMed - indexed for MEDLINE]
Free Article
12.

In vivo evidence that peptide vaccination can induce HLA-DR-restricted CD4+ T cells reactive to a class I tumor peptide.

Harada M, Gohara R, Matsueda S, Muto A, Oda T, Iwamoto Y, Itoh K.

J Immunol. 2004 Feb 15;172(4):2659-67.

PMID:
14764741
[PubMed - indexed for MEDLINE]
Free Article
13.

Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope.

Sotiriadou R, Perez SA, Gritzapis AD, Sotiropoulou PA, Echner H, Heinzel S, Mamalaki A, Pawelec G, Voelter W, Baxevanis CN, Papamichail M.

Br J Cancer. 2001 Nov 16;85(10):1527-34.

PMID:
11720440
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The angiogenic growth factor and biomarker midkine is a tumor-shared antigen.

Kerzerho J, Adotevi O, Castelli FA, Dosset M, Bernardeau K, Szely N, Lang F, Tartour E, Maillere B.

J Immunol. 2010 Jul 1;185(1):418-23. doi: 10.4049/jimmunol.0901014. Epub 2010 May 28.

PMID:
20511550
[PubMed - indexed for MEDLINE]
Free Article
15.

Comprehensive analysis of HLA-DR- and HLA-DP4-restricted CD4+ T cell response specific for the tumor-shared antigen survivin in healthy donors and cancer patients.

Wang XF, Kerzerho J, Adotevi O, Nuyttens H, Badoual C, Munier G, Oudard S, Tu S, Tartour E, Maillère B.

J Immunol. 2008 Jul 1;181(1):431-9.

PMID:
18566409
[PubMed - indexed for MEDLINE]
Free Article
16.

Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.

Bondurant KL, Crew MD, Santin AD, O'Brien TJ, Cannon MJ.

Clin Cancer Res. 2005 May 1;11(9):3446-54.

PMID:
15867247
[PubMed - indexed for MEDLINE]
Free Article
17.

In vitro generated cytolytic T lymphocytes reactive against head and neck cancer recognize multiple epitopes presented by HLA-A2, including peptides derived from the p53 and MDM-2 proteins.

Asai T, Storkus WJ, Mueller-Berghaus J, Knapp W, DeLeo AB, Chikamatsu K, Whiteside TL.

Cancer Immun. 2002 Apr 16;2:3.

PMID:
12747748
[PubMed - indexed for MEDLINE]
Free Article
18.

NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells.

Zarour HM, Storkus WJ, Brusic V, Williams E, Kirkwood JM.

Cancer Res. 2000 Sep 1;60(17):4946-52.

PMID:
10987311
[PubMed - indexed for MEDLINE]
Free Article
19.

The wild-type sequence (wt) p53(25-35) peptide induces HLA-DR7 and HLA-DR11-restricted CD4+ Th cells capable of enhancing the ex vivo expansion and function of anti-wt p53(264-272) peptide CD8+ T cells.

Ito D, Albers A, Zhao YX, Visus C, Appella E, Whiteside TL, DeLeo AB.

J Immunol. 2006 Nov 15;177(10):6795-803.

PMID:
17082593
[PubMed - indexed for MEDLINE]
Free Article
20.

Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3.

Consogno G, Manici S, Facchinetti V, Bachi A, Hammer J, Conti-Fine BM, Rugarli C, Traversari C, Protti MP.

Blood. 2003 Feb 1;101(3):1038-44. Epub 2002 Sep 19.

PMID:
12393675
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk